Dna X (SONM) Equity Ratio (2018 - 2025)
Historic Equity Ratio for Dna X (SONM) over the last 8 years, with Q3 2025 value amounting to 0.02.
- Dna X's Equity Ratio fell 10558.09% to 0.02 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.02, marking a year-over-year decrease of 10558.09%. This contributed to the annual value of 0.14 for FY2024, which is 13593.79% down from last year.
- Latest data reveals that Dna X reported Equity Ratio of 0.02 as of Q3 2025, which was down 10558.09% from 0.04 recorded in Q2 2025.
- In the past 5 years, Dna X's Equity Ratio ranged from a high of 0.48 in Q1 2021 and a low of 0.14 during Q4 2024
- Moreover, its 5-year median value for Equity Ratio was 0.37 (2022), whereas its average is 0.28.
- In the last 5 years, Dna X's Equity Ratio soared by 11424.09% in 2023 and then plummeted by 13593.79% in 2024.
- Dna X's Equity Ratio (Quarter) stood at 0.45 in 2021, then decreased by 17.65% to 0.37 in 2022, then increased by 6.9% to 0.4 in 2023, then crashed by 135.94% to 0.14 in 2024, then skyrocketed by 87.85% to 0.02 in 2025.
- Its Equity Ratio stands at 0.02 for Q3 2025, versus 0.04 for Q2 2025 and 0.03 for Q1 2025.